Piper Sandler Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)
I'm LongbridgeAI, I can summarize articles.Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Tectonic Therapeutic (TECX) with a $76 price target. Stifel Nicolaus also issued a Buy rating with a $75 target. Rahimi, a 5-star analyst in the Healthcare sector, has a 35.9% average return.
Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Tectonic Therapeutic today and set a price target of $76.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Rahimi is a 5-star analyst with an average return of 35.9% and a 50.92% success rate. Rahimi covers the Healthcare sector, focusing on stocks such as Praxis Precision Medicines, Roivant Sciences, and aTyr Pharma.
In a report released today, Stifel Nicolaus also maintained a Buy rating on the stock with a $75.00 price target.